Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Sep;71(9):6593–6602. doi: 10.1128/jvi.71.9.6593-6602.1997

The amino-terminal fusion domain peptide of human immunodeficiency virus type 1 gp41 inserts into the sodium dodecyl sulfate micelle primarily as a helix with a conserved glycine at the micelle-water interface.

D K Chang 1, S F Cheng 1, W J Chien 1
PMCID: PMC191937  PMID: 9261381

Abstract

A peptide based on the N-terminal fusion domain of gp41 of human immunodeficiency virus type 1 (HIV-1) and its tryptophan analog were synthesized to examine the secondary structure in the micellar environment. Nuclear magnetic resonance (NMR), circular dichroism and electron paramagnetic resonance experiments indicated that the gp41 fusion peptide inserted into the micelle primarily as a helix (59%), with substantial beta-structure (26.7%). Deep penetration of the peptide into the apolar hydrocarbon core was supported by the results of fluorescence experiments in which the tryptophan analog exhibited a blue shift of about 30 nm in the presence of a sodium dodecyl sulfate micelle, in 1,2-dimyristoyl-rac-glycero-3-phosphocholine, and in 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine vesicular solutions. The results of spin label-attenuated 1H resonance experiments show that the region C-terminal to G16, which contains a turn structure, exhibited substantial interaction with the micelle, suggesting that it lies on the surface of micelle. Molecular simulation based on data from NMR experiments revealed a flexible hinge at residues 15 and 16 (alanine and glycine, respectively) from the N terminus of the peptide located at the micelle-solution interface. The highly conserved A15-G16 dipeptide may play a role in the function of fusion domain of HIV-1 envelope glycoprotein.

Full Text

The Full Text of this article is available as a PDF (407.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bosch M. L., Earl P. L., Fargnoli K., Picciafuoco S., Giombini F., Wong-Staal F., Franchini G. Identification of the fusion peptide of primate immunodeficiency viruses. Science. 1989 May 12;244(4905):694–697. doi: 10.1126/science.2541505. [DOI] [PubMed] [Google Scholar]
  2. Brasseur R., Vandenbranden M., Cornet B., Burny A., Ruysschaert J. M. Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins. Biochim Biophys Acta. 1990 Nov 16;1029(2):267–273. doi: 10.1016/0005-2736(90)90163-i. [DOI] [PubMed] [Google Scholar]
  3. Brown L. R., Bösch C., Wüthrich K. Location and orientation relative to the micelle surface for glucagon in mixed micelles with dodecylphosphocholine: EPR and NMR studies. Biochim Biophys Acta. 1981 Apr 6;642(2):296–312. doi: 10.1016/0005-2736(81)90447-8. [DOI] [PubMed] [Google Scholar]
  4. Bullough P. A., Hughson F. M., Skehel J. J., Wiley D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 1994 Sep 1;371(6492):37–43. doi: 10.1038/371037a0. [DOI] [PubMed] [Google Scholar]
  5. Cannon B., Polnaszek C. F., Butler K. W., Eriksson L. E., Smith I. C. The fluidity and organization of mitochondrial membrane lipids of the brown adipose tissue of cold-adapted rats and hamsters as determined by nitroxide spin probes. Arch Biochem Biophys. 1975 Apr;167(2):505–518. doi: 10.1016/0003-9861(75)90493-2. [DOI] [PubMed] [Google Scholar]
  6. Clague M. J., Knutson J. R., Blumenthal R., Herrmann A. Interaction of influenza hemagglutinin amino-terminal peptide with phospholipid vesicles: a fluorescence study. Biochemistry. 1991 Jun 4;30(22):5491–5497. doi: 10.1021/bi00236a023. [DOI] [PubMed] [Google Scholar]
  7. Delahunty M. D., Rhee I., Freed E. O., Bonifacino J. S. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues. Virology. 1996 Apr 1;218(1):94–102. doi: 10.1006/viro.1996.0169. [DOI] [PubMed] [Google Scholar]
  8. Dufourcq J., Faucon J. F. Intrinsic fluorescence study of lipid-protein interactions in membrane models. Binding of melittin, an amphipathic peptide, to phospholipid vesicles. Biochim Biophys Acta. 1977 May 16;467(1):1–11. doi: 10.1016/0005-2736(77)90236-x. [DOI] [PubMed] [Google Scholar]
  9. Freed E. O., Myers D. J., Risser R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650–4654. doi: 10.1073/pnas.87.12.4650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gallaher W. R. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell. 1987 Jul 31;50(3):327–328. doi: 10.1016/0092-8674(87)90485-5. [DOI] [PubMed] [Google Scholar]
  11. Gallaher W. R., Segrest J. P., Hunter E. Are fusion peptides really "sided" insertional helices? Cell. 1992 Aug 21;70(4):531–532. doi: 10.1016/0092-8674(92)90423-a. [DOI] [PubMed] [Google Scholar]
  12. Gordon L. M., Curtain C. C., Zhong Y. C., Kirkpatrick A., Mobley P. W., Waring A. J. The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation. Biochim Biophys Acta. 1992 Aug 25;1139(4):257–274. doi: 10.1016/0925-4439(92)90099-9. [DOI] [PubMed] [Google Scholar]
  13. Hennessey J. P., Jr, Johnson W. C., Jr Information content in the circular dichroism of proteins. Biochemistry. 1981 Mar 3;20(5):1085–1094. doi: 10.1021/bi00508a007. [DOI] [PubMed] [Google Scholar]
  14. Johnson W. C., Jr Protein secondary structure and circular dichroism: a practical guide. Proteins. 1990;7(3):205–214. doi: 10.1002/prot.340070302. [DOI] [PubMed] [Google Scholar]
  15. Kragh-Hansen U., Riisom T. Complexes of aliphatic sulfates and human-serum albumin studied by 13C nuclear-magnetic-resonance spectroscopy. Eur J Biochem. 1976 Nov 1;70(1):15–23. doi: 10.1111/j.1432-1033.1976.tb10950.x. [DOI] [PubMed] [Google Scholar]
  16. Kumar A., Ernst R. R., Wüthrich K. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem Biophys Res Commun. 1980 Jul 16;95(1):1–6. doi: 10.1016/0006-291x(80)90695-6. [DOI] [PubMed] [Google Scholar]
  17. Lear J. D., DeGrado W. F. Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2. J Biol Chem. 1987 May 15;262(14):6500–6505. [PubMed] [Google Scholar]
  18. Leis J., Baltimore D., Bishop J. M., Coffin J., Fleissner E., Goff S. P., Oroszlan S., Robinson H., Skalka A. M., Temin H. M. Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol. 1988 May;62(5):1808–1809. doi: 10.1128/jvi.62.5.1808-1809.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Marion D., Wüthrich K. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. Biochem Biophys Res Commun. 1983 Jun 29;113(3):967–974. doi: 10.1016/0006-291x(83)91093-8. [DOI] [PubMed] [Google Scholar]
  20. Mobley P. W., Curtain C. C., Kirkpatrick A., Rostamkhani M., Waring A. J., Gordon L. M. The amino-terminal peptide of HIV-1 glycoprotein 41 lyses human erythrocytes and CD4+ lymphocytes. Biochim Biophys Acta. 1992 Aug 25;1139(4):251–256. doi: 10.1016/0925-4439(92)90098-8. [DOI] [PubMed] [Google Scholar]
  21. Montagnier L., Clavel F., Krust B., Chamaret S., Rey F., Barré-Sinoussi F., Chermann J. C. Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology. 1985 Jul 15;144(1):283–289. doi: 10.1016/0042-6822(85)90326-5. [DOI] [PubMed] [Google Scholar]
  22. Nieva J. L., Nir S., Muga A., Goñi F. M., Wilschut J. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage. Biochemistry. 1994 Mar 22;33(11):3201–3209. doi: 10.1021/bi00177a009. [DOI] [PubMed] [Google Scholar]
  23. Nilges M., Clore G. M., Gronenborn A. M. Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Lett. 1988 Mar 14;229(2):317–324. doi: 10.1016/0014-5793(88)81148-7. [DOI] [PubMed] [Google Scholar]
  24. Piotto M., Saudek V., Sklenár V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR. 1992 Nov;2(6):661–665. doi: 10.1007/BF02192855. [DOI] [PubMed] [Google Scholar]
  25. Rafalski M., Lear J. D., DeGrado W. F. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. Biochemistry. 1990 Aug 28;29(34):7917–7922. doi: 10.1021/bi00486a020. [DOI] [PubMed] [Google Scholar]
  26. Slepushkin V. A., Andreev S. M., Sidorova M. V., Melikyan G. B., Grigoriev V. B., Chumakov V. M., Grinfeldt A. E., Manukyan R. A., Karamov E. V. Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function. AIDS Res Hum Retroviruses. 1992 Jan;8(1):9–18. doi: 10.1089/aid.1992.8.9. [DOI] [PubMed] [Google Scholar]
  27. Stegmann T., Delfino J. M., Richards F. M., Helenius A. The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion. J Biol Chem. 1991 Sep 25;266(27):18404–18410. [PubMed] [Google Scholar]
  28. White J. M. Membrane fusion. Science. 1992 Nov 6;258(5084):917–924. doi: 10.1126/science.1439803. [DOI] [PubMed] [Google Scholar]
  29. Wishart D. S., Sykes B. D. Chemical shifts as a tool for structure determination. Methods Enzymol. 1994;239:363–392. doi: 10.1016/s0076-6879(94)39014-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES